Suppr超能文献

MCM3 蛋白在滤泡型和经典型甲状腺乳头状癌中的表达。

MCM3 protein expression in follicular and classical variants of papillary thyroid carcinoma.

机构信息

Faculty of Medicine, Department of Medical Biology, University of Gaziantep, 27310, Gaziantep, Turkey,

出版信息

Pathol Oncol Res. 2014 Jan;20(1):87-91. doi: 10.1007/s12253-013-9662-9. Epub 2013 Jul 3.

Abstract

Minichromosome maintenance (MCM) proteins are needed as licensors in the DNA replication of eukaryotic cells and transcriptional control of MCM genes has critical role in the regulation of MCM functions. Different MCM protein family members are proposed as diagnostic or prognostic markers in various cancers due to their increased proliferative potential. Among MCM family members, minichromosome maintenance protein 3 (MCM3) expressions in both mRNA and protein levels were shown to be associated with papillary thyroid carcinoma (PTC). But, the usability of MCM3 in some histological variants of PTC might be controversial due to tissue specific molecular heterogeneities. In follicular variant of papillary thyroid carcinoma (FVPTC), a number of genes including MCM3 were shown to be differentially expressed which were specific to this kind of variant. Using immunohistochemistry method, MCM3 protein expression levels were compared in FVPTC, classic variant of papillary thyroid carcinoma (CVPTC), and multi-nodular goiter (MNG) tissues in a group of 32 cases. There was meaningful differences between MNG vs. FVPTC (p = 0.016) and MNG vs. CVPTC (p = 0.019) while there was no significant difference in the comparison FVPTC vs. CVPTC (p = 0.15). Four of the 5 CVPTC cases having surrounding tissue invasion had high expression values. For FVPTC and CVPTC, MCM3 protein expression results were parallel to our previous mRNA expression study while there was downregulation in protein expression despite the increased expression of MCM3 mRNA in MNG suggesting tissue-specific post-transcriptional events in benign thyroid neoplasms of which should be focused on. Moreover, the relatively lower MCM3 protein expression in FVPTC comparing to CVPTC could be due to a different tumorigenic pathway favored in this type of tissue.

摘要

微小染色体维持(MCM)蛋白是真核细胞 DNA 复制所必需的许可因子,MCM 基因的转录调控在调节 MCM 功能方面起着关键作用。由于其增殖潜力增加,不同的 MCM 蛋白家族成员被提议作为各种癌症的诊断或预后标志物。在微小癌(PTC)中,MCM3 在 mRNA 和蛋白水平的表达均与 PTC 相关。但是,由于组织特异性分子异质性,MCM3 在 PTC 的某些组织学变体中的可用性可能存在争议。在滤泡状甲状腺癌(FVPTC)中,包括 MCM3 在内的许多基因的表达被证明是这种变体所特有的。在一组 32 例病例中,使用免疫组织化学方法比较了 FVPTC、经典型甲状腺乳头状癌(CVPTC)和多结节性甲状腺肿(MNG)组织中的 MCM3 蛋白表达水平。MNG 与 FVPTC(p=0.016)和 MNG 与 CVPTC(p=0.019)之间存在显著差异,而 FVPTC 与 CVPTC 之间无显著差异(p=0.15)。5 例 CVPTC 中有 4 例周围组织侵犯者表达值较高。对于 FVPTC 和 CVPTC,MCM3 蛋白表达结果与我们之前的 mRNA 表达研究一致,尽管 MNG 中 MCM3 mRNA 表达增加,但蛋白表达下调,这表明良性甲状腺肿瘤存在组织特异性的转录后事件,应予以关注。此外,与 CVPTC 相比,FVPTC 中 MCM3 蛋白表达水平较低,可能是由于这种组织中存在不同的肿瘤发生途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验